Immunotherapy targeting HPV 16/18 generates potent immune responses in HPV-Associated Head and Neck Cancer

PURPOSE: Clinical responses with programmed death (PD-1) receptor directed antibodies occur in about 20% of patients with advanced head and neck squamous cell cancer (HNSCCa). Viral neoantigens, such as the E6/E7 proteins of HPV16/18 are attractive targets for therapeutic immunization, and offer an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Aggarwal, Charu, Cohen, Roger B., Morrow, Matthew P., Kraynyak, Kimberly A., Sylvester, Albert J., Knoblock, Dawson M., Bauml, Joshua M., Weinstein, Gregory S., Lin, Alexander, Boyer, Jean, Sakata, Lindsay, Tan, Sophie, Anton, Aubrey, Dickerson, Kelsie, Mangrolia, Drishty, Vang, Russell, Dallas, Michael, Oyola, Sandra, Duff, Susan, Esser, Mark, Kumar, Rakesh, Weiner, David, Csiki, Ildiko, Bagarazzi, Mark L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6320307/
https://ncbi.nlm.nih.gov/pubmed/30242022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-1763
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados